Oral GLP-1 drug elecoglipron helps adults lose up to 11.8% body weight

https://www.news-medical.net/news/20260611/Oral-GLP-1-drug-elecoglipron-helps-adults-lose-up-to-11825-body-weight.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=cardiology_newsletter_23_june_2026 A once-daily oral small-molecule GLP-1 receptor agonist delivered progressive, dose-dependent weight loss without food or fluid restrictions, supporting larger phase 3 trials for long-term weight management. In a recent study published in The Lancet, a group of researchers evaluated the efficacy, safety, and tolerability of oral non-peptide small-molecule elecoglipron for weight management in adults with obesity or overweight and at least one weight-related health condition without diabetes.